Could dexmedetomidine have a role in patients admitted with Takotsubo syndrome?
Icahn School of Medicine at Mount Sinai, New York, NY, United States; Division of Cardiology, Elmhust Hospital Center, Elmhust, NY, United States. Electronic address: madiasj@nychhc.org.
John E
JE
Madias
D058647:Adrenergic alpha-2 Receptor Agonists / Q000627:therapeutic use*; D020927:Dexmedetomidine / Q000627:therapeutic use*; D006801:Humans; D010343:Patient Admission; D054549:Takotsubo Cardiomyopathy / Q000188:drug therapy*
D058647:Adrenergic alpha-2 Receptor Agonists; D020927:Dexmedetomidine
Acute phase of Takotsubo syndrome; Dexmedetomidine; Hyperacute phase of Takotsubo syndrome; Pathophysiology of Takotsubo syndrome; Subacute phase of Takotsubo syndrome; Takotsubo syndrome